Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-09-28 00:00:00 ET · period of report 2023-09-26 · accession 0001439222-23-000133 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-28 | 2023-09-26 | AGIO | Jones Cecilia | CFO | M - OptEx | $0.00 | +7,472 | 11.8K | +174% | $0 |
| D | 2023-09-28 | 2023-09-28 | AGIO | Jones Cecilia | CFO | S - Sale+OE | $24.79 | -2,179 | 9,575 | -19% | -$54.0K |
| D | 2023-09-28 | 2023-09-26 | AGIO | Jones Cecilia | CFO | M - OptEx | $0.00 | -7,472 | 14.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-09-26 | M | A | 7,472 | $0.00 | 11,754 | D | — | — | (F1) Includes 499 shares purchased through the Company's employee stock purchase plan. |
| 2 | Common | Common stock | 2023-09-28 | S | D | 2,179 | $24.79 | 9,575 | D | — | — | |
| 3 | Derivative | Restricted stock units | 2023-09-26 | M | D | 7,472 | $0.00 | 14,945 | D | — · — to — | 7,472 Common stock | (F3) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F4) The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. |